Kiat Hoe Ong
- Hematology top 5%
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 4
- Chronic Myeloid Leukemia Treatments 4
- Blood Coagulation and Thrombosis Mechanisms 3
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment 5
- Infectious Diseases top 10%
- COVID-19 Clinical Research Studies 4
-
- Peptidase Inhibition and Analysis 3
-
- Protein Degradation and Inhibitors 3
- Co-authors
- Ponnudurai KuperanBingwen Eugene FanStephrene Seok Wei ChanVanessa Cui Lian ChongK. E. ChooStefan HartYuxin TanAnthony D. William
- Partner nations
- SingaporeUnited StatesMalaysia
In The Last Decade
Kiat Hoe Ong
34 papers receiving 703 citations
Peers
Comparison fields: 5 of 80
- Hematology 210
- Genetics 199
- Infectious Diseases 182
- Internal Medicine 28
- Oncology 170
Countries citing papers authored by Kiat Hoe Ong
This map shows the geographic impact of Kiat Hoe Ong's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kiat Hoe Ong with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kiat Hoe Ong more than expected).
Fields of papers citing papers by Kiat Hoe Ong
This network shows the impact of papers produced by Kiat Hoe Ong. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kiat Hoe Ong. The network helps show where Kiat Hoe Ong may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Kiat Hoe Ong, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 2 | |
| 3 | 2024 | 2 | |
| 4 | 2023 | 7 | |
| 5 | 2022 | 0 | |
| 6 | 2022 | 5 | |
| 7 | 2022 | 7 | |
| 8 | 2021 | 7 | |
| 9 | 2020 | 40 | |
| 10 | 2016 | 3 | |
| 11 | 2013 | 13 | |
| 12 | 2011 | 10 | |
| 13 | 2011 | 105 | |
| 14 | 2011 | 152 | |
| 15 | 2009 | 1 | |
| 16 | 2007 | 11 | |
| 17 | 2006 | 12 | |
| 18 | 2005 | 26 | |
| 19 | 1997 | 15 | |
| 20 | 1994 | 45 |
About Kiat Hoe Ong
Kiat Hoe Ong is a scholar working on Hematology, Genetics and Infectious Diseases, having authored 35 papers that have together received 720 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers), COVID-19 Clinical Research Studies (4 papers), Acute Myeloid Leukemia Research (4 papers), Chronic Myeloid Leukemia Treatments (4 papers), Peptidase Inhibition and Analysis (3 papers), Blood Coagulation and Thrombosis Mechanisms (3 papers) and Protein Degradation and Inhibitors (3 papers). The work is most often cited by research in Hematology (210 citations), Genetics (199 citations) and Infectious Diseases (182 citations). Kiat Hoe Ong has collaborated with scholars based in Singapore, United States and Malaysia. Frequent co-authors include Ponnudurai Kuperan, Bingwen Eugene Fan, Stephrene Seok Wei Chan, Vanessa Cui Lian Chong, K. E. Choo, Stefan Hart, Yuxin Tan, Anthony D. William, Ramesh Jayaraman and Veronica Novotny‐Diermayr.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.